SCHEMBL31542274

SCHEMBL31542274

Cc1cc2c(N3CCN(C)c4ccc(C#N)cc43)cc(C3=CCN(C(=O)OC(C)(C)C)CC3)cc2n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 5/20 0.42
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ KDM1A O60341 1/20 0.38
▸ GRM5 P41594 3/20 0.37
▸ GRM1 Q13255 3/20 0.37
▸ KIT P10721 1/20 0.37
▸ PDK4 Q16654 1/20 0.37
▸ NAMPT P43490 2/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542289 0.86 GRM1 (0.41) ELANEKDM1AGRM5GRM1PDK4
SCHEMBL31542332 0.82 EGLN2 (0.44) GPR119
SCHEMBL31542350 0.81 GPR119 (0.40) GPR119
SCHEMBL26548555 0.77 MAPT (0.37) BRD4GABRA1GABRG2GABRB3GABRA5
SCHEMBL31542292 0.76 NOTCH1 (0.36) GPR119
SCHEMBL31425849 0.76 GRM1 (0.47) BRD4GRM5GRM1KITPDK4
SCHEMBL31542279 0.75 BRPF1 (0.35) BRD4GABRA1GABRG2GABRB3GABRA5
SCHEMBL31542300 0.75 GPR119 (0.41) GPR119
SCHEMBL31542329 0.75 ALK (0.35) GPR119
SCHEMBL26548588 0.74 BRPF1 (0.39) BRD4KDM1AGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025062330-A1 HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS AURIGENE ONCOLOGY LIMITED (IN) 2025-03-27 — — WO disclosed
Send feedback